Selected article for: "confidence interval and random effect model"
Author: Neef, Vanessa; Buxmann, Horst; Rabenau, Holger F.; Zacharowski, Kai; Raimann, Florian J.
Title: Characterization of neonates born to mothers with SARS-CoV-2 infection: review and meta-analysis
  • Cord-id: ddm4s181
  • Document date: 2020_10_24
    • ID: ddm4s181
    Snippet: Objective Characterization of neonates born to mothers with SARS-CoV-2 infection has been partially carried out. There has been no systematic review providing a holistic neonatal presentation including possible vertical transmission. Study design A systematic literature search was performed using PubMed, Google Scholar and Web of Science up to June, 6 2020. Studies on neonates born to mothers with SARS-CoV-2 infection were included. A binary random effect model was used for prevalence and 95% co
    Document: Objective Characterization of neonates born to mothers with SARS-CoV-2 infection has been partially carried out. There has been no systematic review providing a holistic neonatal presentation including possible vertical transmission. Study design A systematic literature search was performed using PubMed, Google Scholar and Web of Science up to June, 6 2020. Studies on neonates born to mothers with SARS-CoV-2 infection were included. A binary random effect model was used for prevalence and 95% confidence interval. Results 32 studies involving 261 neonates were included in meta-analysis. Most neonates born to infected mothers did not show any clinical abnormalities (80.4%). Clinical features were dyspnea in 11 (42.3%) and fever in 9 newborns (19.1%). Of 261 neonates, 120 neonates were tested for infection, of whom 12 (10.0%) tested positive. Swabs from placenta, cord blood and vaginal secretion were negative. Conclusions Neonates are mostly non affected by the mother`s SARS-CoV-2 infection. The risk of vertical transmission is low.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory syndrome sars and low sample size: 1, 2
    • acute respiratory syndrome sars and macrophage shock: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory syndrome sars and macrophage shock activation: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory syndrome sars and macrophage shock activation syndrome: 1, 2, 3, 4, 5, 6, 7, 8